BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 16301744)

  • 1. BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway.
    Craxton A; Draves KE; Gruppi A; Clark EA
    J Exp Med; 2005 Nov; 202(10):1363-74. PubMed ID: 16301744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEK/ERK-mediated phosphorylation of Bim is required to ensure survival of T and B lymphocytes during mitogenic stimulation.
    O'Reilly LA; Kruse EA; Puthalakath H; Kelly PN; Kaufmann T; Huang DC; Strasser A
    J Immunol; 2009 Jul; 183(1):261-9. PubMed ID: 19542438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERK-dependent Bim modulation downstream of the 4-1BB-TRAF1 signaling axis is a critical mediator of CD8 T cell survival in vivo.
    Sabbagh L; Pulle G; Liu Y; Tsitsikov EN; Watts TH
    J Immunol; 2008 Jun; 180(12):8093-101. PubMed ID: 18523273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bim regulates BCR-induced entry of B cells into the cell cycle.
    Craxton A; Draves KE; Clark EA
    Eur J Immunol; 2007 Oct; 37(10):2715-22. PubMed ID: 17705137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL.
    He B; Chadburn A; Jou E; Schattner EJ; Knowles DM; Cerutti A
    J Immunol; 2004 Mar; 172(5):3268-79. PubMed ID: 14978135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-4 regulates Bim expression and promotes B cell maturation in synergy with BAFF conferring resistance to cell death at negative selection checkpoints.
    Granato A; Hayashi EA; Baptista BJ; Bellio M; Nobrega A
    J Immunol; 2014 Jun; 192(12):5761-75. PubMed ID: 24835393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival factor-induced extracellular signal-regulated kinase phosphorylates BIM, inhibiting its association with BAX and proapoptotic activity.
    Harada H; Quearry B; Ruiz-Vela A; Korsmeyer SJ
    Proc Natl Acad Sci U S A; 2004 Oct; 101(43):15313-7. PubMed ID: 15486085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma.
    Ou DL; Shen YC; Liang JD; Liou JY; Yu SL; Fan HH; Wang DS; Lu YS; Hsu C; Cheng AL
    Clin Cancer Res; 2009 Sep; 15(18):5820-8. PubMed ID: 19737956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the MEK/ERK signaling pathway blocks a subset of B cell responses to antigen.
    Richards JD; Davé SH; Chou CH; Mamchak AA; DeFranco AL
    J Immunol; 2001 Mar; 166(6):3855-64. PubMed ID: 11238629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proapoptotic signaling pathway involving RasGRP, Erk, and Bim in B cells.
    Stang SL; Lopez-Campistrous A; Song X; Dower NA; Blumberg PM; Wender PA; Stone JC
    Exp Hematol; 2009 Jan; 37(1):122-134. PubMed ID: 19100522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis induction in human melanoma cells by inhibition of MEK is caspase-independent and mediated by the Bcl-2 family members PUMA, Bim, and Mcl-1.
    Wang YF; Jiang CC; Kiejda KA; Gillespie S; Zhang XD; Hersey P
    Clin Cancer Res; 2007 Aug; 13(16):4934-42. PubMed ID: 17652623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic.
    Cragg MS; Jansen ES; Cook M; Harris C; Strasser A; Scott CL
    J Clin Invest; 2008 Nov; 118(11):3651-9. PubMed ID: 18949058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells.
    Enders A; Bouillet P; Puthalakath H; Xu Y; Tarlinton DM; Strasser A
    J Exp Med; 2003 Oct; 198(7):1119-26. PubMed ID: 14517273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inositol 1,3,4,5-tetrakisphosphate controls proapoptotic Bim gene expression and survival in B cells.
    Maréchal Y; Pesesse X; Jia Y; Pouillon V; Pérez-Morga D; Daniel J; Izui S; Cullen PJ; Leo O; Luo HR; Erneux C; Schurmans S
    Proc Natl Acad Sci U S A; 2007 Aug; 104(35):13978-83. PubMed ID: 17709751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APRIL and BAFF promote increased viability of replicating human B2 cells via mechanism involving cyclooxygenase 2.
    Mongini PK; Inman JK; Han H; Fattah RJ; Abramson SB; Attur M
    J Immunol; 2006 Jun; 176(11):6736-51. PubMed ID: 16709833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined loss of the BH3-only proteins Bim and Bmf restores B-cell development and function in TACI-Ig transgenic mice.
    Woess C; Tuzlak S; Labi V; Drach M; Bertele D; Schneider P; Villunger A
    Cell Death Differ; 2015 Sep; 22(9):1477-88. PubMed ID: 25698446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell receptor-mediated apoptosis of human lymphocytes is associated with a new regulatory pathway of Bim isoform expression.
    Mouhamad S; Besnault L; Auffredou MT; Leprince C; Bourgeade MF; Leca G; Vazquez A
    J Immunol; 2004 Feb; 172(4):2084-91. PubMed ID: 14764673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Expression of Bcl-2 Family Proteins Determines the Sensitivity of Human Follicular Lymphoma Cells to Dexamethasone-mediated and Anti-BCR-mediated Apoptosis.
    Adem J; Ropponen A; Eeva J; Eray M; Nuutinen U; Pelkonen J
    J Immunother; 2016 Jan; 39(1):8-14. PubMed ID: 26641257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin-induced phosphorylation/degradation of BIM contributes to survival of erythroid cells.
    Abutin RM; Chen J; Lung TK; Lloyd JA; Sawyer ST; Harada H
    Exp Hematol; 2009 Feb; 37(2):151-8. PubMed ID: 19100675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell leukemia/lymphoma 1 and galectin-1 regulate survival/cell death pathways in human naive and IgM+ memory B cells through altering balances in Bcl-2 family proteins.
    Tabrizi SJ; Niiro H; Masui M; Yoshimoto G; Iino T; Kikushige Y; Wakasaki T; Baba E; Shimoda S; Miyamoto T; Hara T; Akashi K
    J Immunol; 2009 Feb; 182(3):1490-9. PubMed ID: 19155496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.